Moreover, heparin, which inhibits SARS-CoV-2 by binding to the viral RBD, thereby disrupting virus attachment to cell surface HSPGs and ACE2 (5–7), did not significantly alter the infection of monocytes (Figure 5D), contrary to Caco-2 cells (Figure 5E). This evidence concerns the gene ACE2 and infection.